Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation. 2015 Dec 1;132(22):e273-80. doi: 10.1161/CIR.0000000000000239. Epub 2015 Nov 2.
No abstract available

Keywords: AHA Scientific Statements; arrhythmogenic right ventricular cardiomyopathy; athletes; cardiomyopathy; cardiovascular abnormalities; cardiovascular magnetic resonance; hypertrophic cardiomyopathy; myocarditis; sudden death.

Publication types

  • Review

MeSH terms

  • Advisory Committees
  • American Heart Association*
  • Arrhythmogenic Right Ventricular Dysplasia / diagnosis*
  • Arrhythmogenic Right Ventricular Dysplasia / epidemiology
  • Athletes*
  • Cardiology / methods
  • Cardiology / standards*
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / epidemiology
  • Cardiomyopathy, Hypertrophic / diagnosis*
  • Cardiomyopathy, Hypertrophic / epidemiology
  • Cardiovascular Abnormalities / diagnosis*
  • Cardiovascular Abnormalities / epidemiology
  • Humans
  • Myocarditis / diagnosis*
  • Myocarditis / epidemiology
  • Practice Guidelines as Topic / standards
  • United States / epidemiology